Fin Trust Capital Advisors, LLC Anavex Life Sciences Corp. Transaction History

Fin Trust Capital Advisors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 03, 2022	SELL	$9.74 - $17.69 $24,837 - $45,109	-2,550 Reduced 85.0%	450 $6,000
Q4 2021 Feb 14, 2022	BUY	$16.88 - $23.31 $9,706 - $13,403	575 Added 23.71%	3,000 $52,000
Q3 2021 Nov 16, 2021	BUY	$16.82 - $25.75 $40,788 - $62,443	2,425 New	2,425 $44,000

166

26.6M

518K

838K

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $663M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

Get notified when there are updates to the investment portfolio of Fin Trust Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Fin Trust Capital Advisors, LLC with notifications on news.